Nonalcoholic steatohepatitis is a syndrome causes liver damage develops in the individuals who are not alcoholic. The primary mechanisms of nonalcoholic steatohepatitis are obesity, glucose intolerance, metabolic stress, inflammation, dyslipidemia and fibrosis. Nonalcoholic steatohepatitis can develop into cirrhosis and liver cancer. For the diagnosis of the nonalcoholic steatohepatitis, liver biopsy, imaging procedures and various types of blood tests including complete blood count, fasting blood sugar, liver enzyme tests etc. are required. The common nonalcoholic steatohepatitis treatment may include weight loss, type-2 diabetes treatment, a decrease of obesity etc. However, many drugs have been tested for the nonalcoholic steatohepatitis treatment only a few drugs such as vitamin E and pioglitazone showed a positive effect. Other drugs such as ursodeoxycholic acid, metformin, statins, orlistat and pentoxifylline showed only partially positive results.The major elements that can be considered for the pathological protagonists of nonalcoholic steatohepatitis are oxidative stress, altered lipid metabolism adipose and pancreas tissues, bile acids, gut microbiota, bacterial endotoxins, and systemic chronic inflammation.
This report aims to provide a comprehensive presentation of the global market for Nonalcoholic Steatohepatitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonalcoholic Steatohepatitis Treatment. This report contains market size and forecasts of Nonalcoholic Steatohepatitis Treatment in global, including the following market information:
Global Nonalcoholic Steatohepatitis Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Nonalcoholic Steatohepatitis Treatment Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Nonalcoholic Steatohepatitis Treatment companies in 2022 (%)
The global Nonalcoholic Steatohepatitis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Solid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nonalcoholic Steatohepatitis Treatment include AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, Roche, Vivus, Arisaph Pharmaceuticals, Cempra Pharmaceuticals and Galectin Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nonalcoholic Steatohepatitis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonalcoholic Steatohepatitis Treatment Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, by Type, 2022 (%)
Solid
Liquid
Global Nonalcoholic Steatohepatitis Treatment Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Diagnostic Center
Specialized Clinic
Hospital Pharmacy
Drug Store
Mail Order Pharmacy
Global Nonalcoholic Steatohepatitis Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nonalcoholic Steatohepatitis Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nonalcoholic Steatohepatitis Treatment revenues share in global market, 2022 (%)
Key companies Nonalcoholic Steatohepatitis Treatment sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Nonalcoholic Steatohepatitis Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nonalcoholic Steatohepatitis Treatment, market overview.
Chapter 2: Global Nonalcoholic Steatohepatitis Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Nonalcoholic Steatohepatitis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nonalcoholic Steatohepatitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nonalcoholic Steatohepatitis Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nonalcoholic Steatohepatitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nonalcoholic Steatohepatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nonalcoholic Steatohepatitis Treatment Overall Market Size
2.1 Global Nonalcoholic Steatohepatitis Treatment Market Size: 2022 VS 2032
2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Nonalcoholic Steatohepatitis Treatment Sales: 2018-2032
3 Company Landscape
3.1 Top Nonalcoholic Steatohepatitis Treatment Players in Global Market
3.2 Top Global Nonalcoholic Steatohepatitis Treatment Companies Ranked by Revenue
3.3 Global Nonalcoholic Steatohepatitis Treatment Revenue by Companies
3.4 Global Nonalcoholic Steatohepatitis Treatment Sales by Companies
3.5 Global Nonalcoholic Steatohepatitis Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Nonalcoholic Steatohepatitis Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Nonalcoholic Steatohepatitis Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nonalcoholic Steatohepatitis Treatment Players in Global Market
3.8.1 List of Global Tier 1 Nonalcoholic Steatohepatitis Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Nonalcoholic Steatohepatitis Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nonalcoholic Steatohepatitis Treatment Market Size Markets, 2022 & 2032
4.1.2 Solid
4.1.3 Liquid
4.2 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue & Forecasts
4.2.1 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2018-2023
4.2.2 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2024-2032
4.2.3 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
4.3 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales & Forecasts
4.3.1 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales, 2018-2023
4.3.2 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales, 2024-2032
4.3.3 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
4.4 By Type - Global Nonalcoholic Steatohepatitis Treatment Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nonalcoholic Steatohepatitis Treatment Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Diagnostic Center
5.1.4 Specialized Clinic
5.1.5 Hospital Pharmacy
5.1.6 Drug Store
5.1.7 Mail Order Pharmacy
5.2 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue & Forecasts
5.2.1 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2018-2023
5.2.2 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2024-2032
5.2.3 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
5.3 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales & Forecasts
5.3.1 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales, 2018-2023
5.3.2 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales, 2024-2032
5.3.3 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
5.4 By Application - Global Nonalcoholic Steatohepatitis Treatment Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Nonalcoholic Steatohepatitis Treatment Market Size, 2022 & 2032
6.2 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue & Forecasts
6.2.1 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2018-2023
6.2.2 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2024-2032
6.2.3 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
6.3 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales & Forecasts
6.3.1 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales, 2018-2023
6.3.2 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales, 2024-2032
6.3.3 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue, 2018-2032
6.4.2 By Country - North America Nonalcoholic Steatohepatitis Treatment Sales, 2018-2032
6.4.3 US Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.4.4 Canada Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.4.5 Mexico Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue, 2018-2032
6.5.2 By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales, 2018-2032
6.5.3 Germany Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.5.4 France Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.5.5 U.K. Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.5.6 Italy Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.5.7 Russia Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.5.8 Nordic Countries Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.5.9 Benelux Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue, 2018-2032
6.6.2 By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales, 2018-2032
6.6.3 China Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.6.4 Japan Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.6.5 South Korea Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.6.6 Southeast Asia Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.6.7 India Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue, 2018-2032
6.7.2 By Country - South America Nonalcoholic Steatohepatitis Treatment Sales, 2018-2032
6.7.3 Brazil Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.7.4 Argentina Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, 2018-2032
6.8.3 Turkey Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.8.4 Israel Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.8.5 Saudi Arabia Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
6.8.6 UAE Nonalcoholic Steatohepatitis Treatment Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.1.4 AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Arena Pharmaceuticals
7.2.1 Arena Pharmaceuticals Company Summary
7.2.2 Arena Pharmaceuticals Business Overview
7.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.2.5 Arena Pharmaceuticals Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.3.4 GSK Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.4.4 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.5.4 Roche Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Vivus
7.6.1 Vivus Company Summary
7.6.2 Vivus Business Overview
7.6.3 Vivus Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.6.4 Vivus Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.6.5 Vivus Key News & Latest Developments
7.7 Arisaph Pharmaceuticals
7.7.1 Arisaph Pharmaceuticals Company Summary
7.7.2 Arisaph Pharmaceuticals Business Overview
7.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.7.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.7.5 Arisaph Pharmaceuticals Key News & Latest Developments
7.8 Cempra Pharmaceuticals
7.8.1 Cempra Pharmaceuticals Company Summary
7.8.2 Cempra Pharmaceuticals Business Overview
7.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.8.5 Cempra Pharmaceuticals Key News & Latest Developments
7.9 Galectin Therapeutics
7.9.1 Galectin Therapeutics Company Summary
7.9.2 Galectin Therapeutics Business Overview
7.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.9.5 Galectin Therapeutics Key News & Latest Developments
7.10 Galmed Pharmaceuticals
7.10.1 Galmed Pharmaceuticals Company Summary
7.10.2 Galmed Pharmaceuticals Business Overview
7.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.10.5 Galmed Pharmaceuticals Key News & Latest Developments
7.11 Genfit
7.11.1 Genfit Company Summary
7.11.2 Genfit Nonalcoholic Steatohepatitis Treatment Business Overview
7.11.3 Genfit Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.11.4 Genfit Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.11.5 Genfit Key News & Latest Developments
7.12 Gilead
7.12.1 Gilead Company Summary
7.12.2 Gilead Nonalcoholic Steatohepatitis Treatment Business Overview
7.12.3 Gilead Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.12.4 Gilead Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2018-2023)
7.12.5 Gilead Key News & Latest Developments
8 Global Nonalcoholic Steatohepatitis Treatment Production Capacity, Analysis
8.1 Global Nonalcoholic Steatohepatitis Treatment Production Capacity, 2018-2032
8.2 Nonalcoholic Steatohepatitis Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Nonalcoholic Steatohepatitis Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nonalcoholic Steatohepatitis Treatment Supply Chain Analysis
10.1 Nonalcoholic Steatohepatitis Treatment Industry Value Chain
10.2 Nonalcoholic Steatohepatitis Treatment Upstream Market
10.3 Nonalcoholic Steatohepatitis Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nonalcoholic Steatohepatitis Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Nonalcoholic Steatohepatitis Treatment in Global Market
Table 2. Top Nonalcoholic Steatohepatitis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Nonalcoholic Steatohepatitis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Companies, 2018-2023
Table 5. Global Nonalcoholic Steatohepatitis Treatment Sales by Companies, (K Units), 2018-2023
Table 6. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Nonalcoholic Steatohepatitis Treatment Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Nonalcoholic Steatohepatitis Treatment Product Type
Table 9. List of Global Tier 1 Nonalcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nonalcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2018-2023
Table 15. By Type - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2024-2032
Table 16. By Application ? Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2018-2023
Table 20. By Application - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2024-2032
Table 21. By Region ? Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2018-2023
Table 25. By Region - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2024-2032
Table 26. By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2018-2023
Table 29. By Country - North America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2024-2032
Table 30. By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2018-2023
Table 33. By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2024-2032
Table 34. By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2018-2023
Table 37. By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2024-2032
Table 38. By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2018-2023
Table 41. By Country - South America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2024-2032
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 48. AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Arena Pharmaceuticals Company Summary
Table 51. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 52. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Arena Pharmaceuticals Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 56. GSK Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. GSK Key News & Latest Developments
Table 58. Novo Nordisk Company Summary
Table 59. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 60. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Novo Nordisk Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 64. Roche Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Roche Key News & Latest Developments
Table 66. Vivus Company Summary
Table 67. Vivus Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 68. Vivus Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Vivus Key News & Latest Developments
Table 70. Arisaph Pharmaceuticals Company Summary
Table 71. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 72. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Arisaph Pharmaceuticals Key News & Latest Developments
Table 74. Cempra Pharmaceuticals Company Summary
Table 75. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 76. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Cempra Pharmaceuticals Key News & Latest Developments
Table 78. Galectin Therapeutics Company Summary
Table 79. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 80. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Galectin Therapeutics Key News & Latest Developments
Table 82. Galmed Pharmaceuticals Company Summary
Table 83. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 84. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Galmed Pharmaceuticals Key News & Latest Developments
Table 86. Genfit Company Summary
Table 87. Genfit Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 88. Genfit Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Genfit Key News & Latest Developments
Table 90. Gilead Company Summary
Table 91. Gilead Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 92. Gilead Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Gilead Key News & Latest Developments
Table 94. Nonalcoholic Steatohepatitis Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Nonalcoholic Steatohepatitis Treatment Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Nonalcoholic Steatohepatitis Treatment Production by Region, 2018-2023 (K Units)
Table 97. Global Nonalcoholic Steatohepatitis Treatment Production by Region, 2024-2032 (K Units)
Table 98. Nonalcoholic Steatohepatitis Treatment Market Opportunities & Trends in Global Market
Table 99. Nonalcoholic Steatohepatitis Treatment Market Drivers in Global Market
Table 100. Nonalcoholic Steatohepatitis Treatment Market Restraints in Global Market
Table 101. Nonalcoholic Steatohepatitis Treatment Raw Materials
Table 102. Nonalcoholic Steatohepatitis Treatment Raw Materials Suppliers in Global Market
Table 103. Typical Nonalcoholic Steatohepatitis Treatment Downstream
Table 104. Nonalcoholic Steatohepatitis Treatment Downstream Clients in Global Market
Table 105. Nonalcoholic Steatohepatitis Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nonalcoholic Steatohepatitis Treatment Segment by Type in 2022
Figure 2. Nonalcoholic Steatohepatitis Treatment Segment by Application in 2022
Figure 3. Global Nonalcoholic Steatohepatitis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nonalcoholic Steatohepatitis Treatment Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Nonalcoholic Steatohepatitis Treatment Revenue, 2018-2032 (US$, Mn)
Figure 7. Nonalcoholic Steatohepatitis Treatment Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nonalcoholic Steatohepatitis Treatment Revenue in 2022
Figure 9. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
Figure 11. By Type - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
Figure 12. By Type - Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit), 2018-2032
Figure 13. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
Figure 15. By Application - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
Figure 16. By Application - Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit), 2018-2032
Figure 17. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
Figure 20. By Region - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
Figure 21. By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
Figure 22. By Country - North America Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
Figure 23. US Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
Figure 28. Germany Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 29. France Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
Figure 37. China Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 41. India Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
Figure 43. By Country - South America Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
Figure 44. Brazil Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2018-2032
Figure 48. Turkey Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2032
Figure 52. Global Nonalcoholic Steatohepatitis Treatment Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Nonalcoholic Steatohepatitis Treatment by Region, 2022 VS 2032
Figure 54. Nonalcoholic Steatohepatitis Treatment Industry Value Chain
Figure 55. Marketing Channels
